Novo Nordisk (NVO) closed the most recent trading day at $117.81, moving -1.64% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.76%. Elsewhere, the ...
Danish pharma company asserts 10 patents for drug that improves blood sugar levels in Type 2 diabetes patients | Like Novo’s ...
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...